HPR160 Analysis of the Time Spent by AIFA Committees for the Assessment of New Drugs: Impact of the Application of Managed Entry Agreements

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1289
https://www.valueinhealthjournal.com/article/S1098-3015(22)03494-5/fulltext
Title : HPR160 Analysis of the Time Spent by AIFA Committees for the Assessment of New Drugs: Impact of the Application of Managed Entry Agreements
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03494-5&doi=10.1016/j.jval.2022.09.1289
First page :
Section Title :
Open access? : No
Section Order : 10835
Categories :
Tags :
Regions :
ViH Article Tags :